MONITORING HEPARIN AND PROTAMINE THERAPY DURING CARDIOPULMONARY BYPASS BY ACTIVATED CLOTTING TIME

被引：0
|
作者：
BERG, E
STENBJERG, S
ALBRECHTSEN, OK
机构：
来源：
JOURNAL OF EXTRA-CORPOREAL TECHNOLOGY | 1979年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：229 / 235
页数：7
相关论文
共 50 条
  • [21] COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS BY HEPARIN PROTAMINE INTERACTION
    BEST, N
    SINOSICH, MJ
    TEISNER, B
    GRUDZINSKAS, JG
    FISHER, MM
    BRITISH JOURNAL OF ANAESTHESIA, 1984, 56 (04) : 339 - 343
  • [22] MEASUREMENT OF THE ACTIVATED CLOTTING TIME (ACT) DURING CARDIOPULMONARY BYPASS IN CHILDREN - IS IT RELEVANT
    HORKAY, F
    MARTIN, P
    SAEED, W
    RAJAH, SM
    WALKER, DR
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1028 - 1028
  • [23] CONTROL OF HEPARINIZATION DURING CARDIOPULMONARY BYPASS - EXPERIENCE WITH THE ACTIVATED CLOTTING TIME METHOD
    KAMATH, BSK
    FOZARD, JR
    ANAESTHESIA, 1980, 35 (03) : 250 - 256
  • [24] Pro: The Hepcon HMS Should Be Used Instead of Traditional Activated Clotting Time (ACT) to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass
    Ural, Kelly
    Owen, Christopher
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2016, 30 (06) : 1727 - 1729
  • [25] Intrinsic pathway-dependent activated clotting time is not reliable for monitoring anticoagulation during cardiopulmonary bypass in neonates
    Gu, YJ
    Huyzen, RJ
    vanOeveren, W
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (03): : 677 - 678
  • [26] Activated Coagulation Time and Hepcon Protamine Titration Device to Manage Unfractionated Heparin During Cardiopulmonary Bypass in a Hemophilia A Patient on Emicizumab
    Isaacs, James
    Welsby, Ian J.
    Schroder, Jacob N.
    Onwuemene, Oluwatoyosi A.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 35 (11) : 3299 - 3302
  • [27] APROTININ AND HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS
    HUNT, BJ
    SEGAL, H
    YACOUB, M
    CIRCULATION, 1992, 86 (05) : 410 - 412
  • [28] HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS (CPB)
    SALEHSHENAQ, S
    SALEEM, A
    YAWN, D
    HARSBERGER, K
    DIEMUNSCH, P
    MOHINDRA, P
    ANESTHESIA AND ANALGESIA, 1984, 63 (02): : 271 - 271
  • [29] Factors associated with activated clotting time following heparin administration in pediatric cardiopulmonary bypass: A retrospective study
    Hida, Mizuho
    Kashiwa, Koichi
    Kurosawa, Hideo
    Takahashi, Mai
    Fujiya, Saori
    Fujishiro, Kazuki
    Shimoda, Junpei
    Kubo, Hitoshi
    Inokuchi, Ryota
    Doi, Kent
    Hirata, Yasutaka
    PERFUSION-UK, 2025,
  • [30] Utility of in vitro heparin and protamine titration for dosing during cardiopulmonary bypass
    Zucker, ML
    LaDuca, FM
    Barrett, C
    Bennett, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2795 - P2795
12345